abt-199
Showing 1 - 13 of 13
Chronic Lymphocytic Leucemia Trial in Cologne (Bendamustine, GA101, ABT-199)
Active, not recruiting
- Chronic Lymphocytic Leucemia
- Bendamustine
- +2 more
-
Cologne, GermanyGerman CLL Study Group
Sep 14, 2022
Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, United States (ABT-199, Rituximab)
Completed
- Small Lymphocytic Lymphoma
- Chronic Lymphocytic Leukemia
- ABT-199
- Rituximab
-
La Jolla, California
- +5 more
Jul 11, 2022
Relapsed DLBCL, Refractory DLBCL Trial in Hackensack (ABT-199, Ibrutinib, Rituximab)
Active, not recruiting
- Relapsed Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
- ABT-199
- +2 more
-
Hackensack, New JerseyJohn Theurer Cancer Center at Hackensack University Medical Cent
Oct 7, 2022
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)
Completed
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
- ABT-199
-
Tucson, Arizona
- +9 more
Feb 10, 2022
Non-Hodgkin's Lymphoma Trial in United States (ABT-199, Rituximab, Bendamustine)
Completed
- Non-Hodgkin's Lymphoma
- ABT-199
- +2 more
-
La Jolla, California
- +7 more
Jul 29, 2021
Chronic Lymphocytic Leukemia Trial in United States (ABT-199)
Completed
- Chronic Lymphocytic Leukemia
- ABT-199
-
La Jolla, California
- +14 more
Dec 29, 2021
Relapsed/Refractory Multiple Myeloma Trial in Australia, France, United States (ABT-199, bortezomib, dexamethasone)
Completed
- Relapsed/Refractory Multiple Myeloma
- ABT-199
- +2 more
-
Tucson, Arizona
- +8 more
Jul 29, 2021
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (Dexamethasone, ABT-199)
Completed
- Relapsed/Refractory Multiple Myeloma
- Dexamethasone
- ABT-199
-
Scottsdale, Arizona
- +28 more
Nov 18, 2021
Non-Hodgkin's Lymphoma Trial in Tucson, Lebanon, Hackensack (ABT-199)
Completed
- Non-Hodgkin's Lymphoma
- ABT-199
-
Tucson, Arizona
- +2 more
Dec 18, 2019
Acute Myelogenous Leukemia, AML, Acute Myeloid Leukemia Trial (ABT-199)
Completed
- Acute Myelogenous Leukemia
- +2 more
- ABT-199
- (no location specified)
May 2, 2018
Lupus Erythematosus Trial in Worldwide (ABT-199, Placebo)
Completed
- Lupus Erythematosus
- ABT-199
- Placebo
-
Clearwater, Florida
- +14 more
Nov 16, 2017
Non-Hodgkin's Lymphoma Trial in Hackensack (ABT-199, Rifampin)
Withdrawn
- Non-Hodgkin's Lymphoma
- ABT-199
- Rifampin
-
Hackensack, New JerseySite Reference ID/Investigator# 101416
May 22, 2014